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Infection with HIV leads to immunosuppression and up to 90% of HIV infected individuals contract fungal 
infections of which 10 - 20% die as a direct consequence of these infections. In the present study, 76 
extracts from 30 plants used by Venda traditional healers for the treatment of fungal related ailments, 
were tested for their antifungal activities against clinical isolates of Candida albicans, Candida krusei and 
Cryptococcus neoformans using the agar diffusion and the microdilution methods. The minimum 
fungicidal concentrations as well as the time kill curves of the thee most active plants were also 
determined. Extracts from 25 plants (83.3%) were active against C. albicans, C. krusei or C. neoformans. 
Thirty two extracts were active against C. neoformans, while 15 were active against C. albicans and 12 
were active against C. krusei. Warburgia salutaris, Cassine transvaalensis, Piper capense, Maerua edulis, 
Pseudolachnostylis maprouneifolia, Berchemia discolor and Lippia javanica were not only inhibitory to 
fungal growth but also had fungicidal effects against one or all the 3 fungi tested (MIC/MFC between 0.11 
and 7.5 mg/ml). Hexane extracts were also active indicating that many of the antifungal components of 
these plants are non-polar compounds. Time-to- kill experiments indicated an intense time-dependent 
fungicidal effect against C. albicans, achieving over a 5 h-period a 6 log10-unit decrease in CFU/ml at a 
concentration of 0.4 mg/ml for W. salutaris. The present study justifies the traditional use of these plants 
for the treatment of opportunistic infections in the region. 
 





Acquired immune deficiency syndrome (AIDS) caused by 
the human immunodeficiency virus (HIV) is a devastating 
epidemic in Africa and South Africa has been reported to 
have had the fastest growing rate of HIV/AIDS epidemic 
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90% of all HIV patients contract fungal infections during 
the course of the disease, of which 10 - 20% die as a 
direct consequence of fungal infections (Hamza et al., 
2006; Back-Brito et al., 2008). Candida albicans and 
Cryptococcus neoformans are the most common oppor-
tunistic infections in HIV/AIDS patients (Fan-Harvard et 
al., 1991) and management of such infections particularly 
in HIV/AIDS patients is faced with some difficulties, such 
as resistance to antifungal agents, drug toxicity and high 
cost of antifungal agents (Debruyne, 1997; Traeder et al., 
2008). Therefore, there is a need to search for alternative  
 




control methods and the utilization of medicinal plants by 
the local populations constitutes  an  important  source  of 
new active and renewable antifungal drugs.  
Many potent drugs including anti-malarial, anti-bacterial 
and anti-diabetic compounds have been purified from 
medicinal plants (Schmidt et al., 2008). For centuries, 
plants have been used by indigenous people to produce 
medicines that were used to treat different kinds of 
ailments. Up to 80% of populations living in Africa rely on 
medicinal plants (Elujoba et al., 2005). In Venda, 
geographically located in the Northeast of South Africa, 
the use of medicinal plants is very common based on 
local traditions as well as the availability of highly diverse 
genetic resources (van Vuuren, 2008). Traditional doctors 
and elders use several plants to treat different types of 
infections including those caused by fungal organisms. 
The preferred parts of specific medicinal plants are 
collected each at its favorable harvest season, dried by 
directly exposing them to sunlight, pounded using pestle 
and mortar and then stored in containers in powder form 
for future usage. The part of the plant used varies among 
species and traditional healers and also depends on the 
nature and state of the disease (Mabogo, 1990).  
Previous studies on Venda medicinal plants have 
concentrated on the antibacterial activity and very few 
studies have targeted the antifungal activities of Venda 
medicinal plants (Obi et al., 2003; Tshikalange et al., 
2005; McGaw et al., 2007). Plants are not only important 
to the millions of people to whom traditional medicine 
serves as the only opportunity for health care and to 
those who use plants for various purposes in their daily 
lives, but also as a source of new pharmaceuticals (de 
Boer et al., 2005). Commercially available antifungal 
drugs are expensive and some fungal species are 
developing resistance against them and therefore 
screening for more medicinal plants with antifungal 
activities can help in the identification and development of 
more active and affordable drugs. In the present study, 
medicinal plants used by traditional healers in the Venda 
region were investigated for their antifungal activities 
against C. albicans, Candida krusei and Cryptococcus 
neoformans isolated from South African AIDS patients.  
 
 
MATERIALS AND METHODS 
 
Ethnobotanical data and plant material collection 
 
Ethnobotanical information on medicinal plants that are used by the 
Vha-Vendas to treat fungal infections was attained though visits and 
interviews with two, male traditional doctors aged between 45 and 
60 years from two different areas in the Vhembe district 
(Thohoyandou and Nzhelele) situated in the North-eastern part of 
South Africa 60 km from the Kruger National Park. Identification and 
collection of medicinal plants was done under the supervision of the 
traditional healers to avoid confusion and nature destruction. The 
plants were further identified by botanists from the Department of 
Botany (University of Venda) and the Thohoyandou Botanical 
Garden. The voucher specimens of the plants investigated were 
kept in the Department of Botany, University of Venda and the 







The fungal organisms used in the present study were isolated from 
AIDS patients with oro-pharyngeal thrush and cryptococcal 
meningitis. C. albicans was isolated from a 28 year old female (CD4 
count of 54/mm3) while C. krusei was isolated from a 45 years old 
male patient (CD4 count of 115/mm3). Candida species were 
identified using CHOM agar following the manufacturer’s 
instructions (CHOMagar, Paris, France). C. neoformans was 
isolated from the cerebrospinal fluid obtained from a 29 year old 
female patient (CD4 cells count 94/mm3) with cryptococcal 
meningitis. The Candida species were susceptible to nystatin, while 
Cryptococcus was susceptible to 5 -fluorocytosine. Nystatin and 5 -
fluorocytosine were used as positive controls in the present study. 
 
 
Plant sample preparations 
 
Plant materials collected from Nzhelele and Thohoyandou between 
May and August 2007 were dried at room temperature for about 2 
weeks or using an incubator at 40°C for 2 to 3 days. The dried plant 
materials were ground into powder form using a grinder followed by 





50 g of the ground material of each plant was extracted in 500ml of 
each of two solvents (acetone and hexane) under continuous 
shaking for 24 h. The extract was filtered through a 22 µm paper 
filter. The filtrate was evaporated to dryness using a rotatory 
evaporator at 40°C. The residues in the form of powder or oily 
material were preserved in sterile glass bottles in a cool dark place 
until use.  
 
 
Antifungal activity test 
 
Agar diffusion and micro-dilution methods were used to determine 
the antifungal activities of the medicinal plant extracts against C. 
albicans, C. krusei and C. neoformans. Sabouraud dextrose broth 
(SDB) was used for the preparation of fungal cultures and for the 
determination of the MIC and was prepared following the 
manufacturer’s instructions. Sabouraud dextrose agar (SDA) was 
used to determine the activity of the plant extracts against the 




Agar diffusion assay 
 
Using the micropipette, 100 l of 1Mcfarland solution of C. albicans 
culture (in SDB) was spread over the surface of an agar plate using 
a sterile hockey stick. The same procedure was followed for C. 
krusei and C. neoformans. Using a sterile 5 cm plastic pipette, four 
holes were punched (2 mm in diameter) in each of the culture 
plates. In the first hole, 10 l of the drug was added as positive 
control; 10 l of DMSO was added as a negative control in the 
second hole; 5 and 10 l of the plant extract were added in the third 
and last holes. The culture plates were then incubated at 37°C and 
the results were observed after 24 h. The clear zone around the 
plant extract was measured in mm and indicated the activity of the 
plant extract against the fungal organisms. The experiments were 











inhibitory concentration (MIC) of the plant extracts using 96 well 
microtitration plates as previously described (Samie et al., 2005). 
Briefly, 185 l of the broth was added into each well in the first row 
of microtitration plate and 100 l to the rest of the wells from the 
second row downwards. 15 l of the plant extracts was then added 
into each well on the first row (row A), starting with the positive 
control (Nystatin, Roche), followed by the negative control (the 20% 
DMSO used to dissolve the plant extracts) and the plant extracts in 
the rest of the wells on that row. A twofold serial dilution was done 
by mixing the contents in each well of the first row and transferring 
100 l to the second well of the same column and the same was 
done up to the last well of the same column and the last 100 l from 
the last well was discarded. Then 100 l of yeast suspensions was 
added. The results were observed after 24 h incubation at 37°C 
followed by the addition of 40 l of a 0.2% Iodo Nitro Tetrazolium 
(INT) solution after a further incubation of 4 h at 37°C. The wells 
that did not show any colour change after INT was added indicating 
the concentration of the plant extract that was able to inhibit fungal 
growth whereas the pink colour change indicated fungal growth. 
 
 
Determination of the MFC (minimum fungicidal concentration) 
 
The MFC was determined by inoculating the contents from the MIC 
plates onto SDA plates and the results were observed after 24 h 
incubation at 37°C. The presence of the fungal colonies on agar 
plates was an indication that the plant extract only inhibited the 
growth of the fungi without killing them and the absence indicated 
that the plant extract was able to kill the fungal organisms. The 
smallest concentration of the plant extract that was able to kill the 




Time - kill experiment 
 
Determination of the rate of kill of the crude extract was done 
following the procedure described by Aiyegoro et al. (2008) with 
slight modifications. Briefly, inocula were prepared as described 
above. The resultant suspension was diluted 1:100 with fresh sterile 
broth and used to inoculate 50 ml volumes of SDB incorporated 
with extract at MFC to a final cell density of approximately 2 × 106 
cfu/ml. The flasks were incubated at 37°C on an orbital shaker at 
120 rpm. A 500 l sample was removed from cultures at 0, 2, 5, 10 
and 24 h, diluted serially and 100 l of the diluted samples were 
plated on SDA plates and incubated at 37°C for 24 h. Controls 






Ethnobotanical information on plants used to treat 
fungal and similar infections in the Venda region 
 
The visits and interviews with traditional healers revealed 
about 30 extracts used for the treatment of fungal related 
ailments. Some of the plants have also been described 
by Mabogo (1990). Table 1 describes the plants as well 
as their traditional use and the part used. Most of the 
plants were used for several ailments and in most cases 
many plants were used at the same time for different 
ailments and the combination of the plants varied with the 
ailment and the traditional healer. Of the 30 plants tested 
in   the   present  study,  11  have  been  tested  by  other  




authors (Gundidza and Sibanda, 1991; Motsei et al., 
2003; Hamza et al., 2006; Steenkamp et al., 2007). 
Information on plants previously tested with proven 
activity is presented in Table 2. However, only 10 
according to previous studies had proven anti-C. albicans 
activity while one of them (Strychnos decussata) did not 
show activity even though in the present study we found 
that this plant was active against C. neoformans (disc 
diffusion method: Table 3) as well as the two Candida 
species tested (microdilution method: Table 4).  
 
 
Antifungal activity of medicinal plants 
 
Out of the 76 plant extracts from 30 plants tested against 
the 3 fungal organisms, 38 (50%) extracts from 26 
(83.3%) plants were active against at least one of the 
organisms. 33 extracts were active against C. 
neoformans with zones of inhibition varying from 5 to 20 
mm. 13 extracts were active against C. albicans and 10 
were active against C. krusei. The highest activity was 
obtained with Piper capense acetone root extract with a 
22 mm zone of inhibition against C. albicans and C. 
krusei. Warburgia salutaris hexane bark extracts was the 
most active against C. neoformans. Cassine 
transvaalensis (was active against all the three fungi 
although only the hexane extract from the bark was active 
and the acetone extract was not active against any of the 
tested fungi. Berchemia discolor and P. capense also 
inhibited all the tested fungi. In many instances, the 
acetone extracts were active against C. neoformans. This 
was observed with Banksia micrantha, Diospyros 
mespiliformis, Passiflora mixta, Schotia brachypetala, 
Ziziphus mucronata, Sclerocarya birrea, R. tridentate, R. 
rogesii, Pygeum africanum and Bauhinia galpinii. How-
ever, hexane extracts were more active such as observed 
with C. transvaalensis, Ximenia caffra, Euclea divinorum, 
S. decussata, Terminalia sericea, Amorpha fruticosa, 
Pseudolachnostylis maprouneifolia, B. discolor, B. molis 
of which the hexane extracts was more active against C. 
neoformans, while hexane extracts of Lippia javanica, D. 
mespiliformis, P. maprouneifolia were active against C. 
albicans or C. krusei. Table 3 presents the results 
obtained from the agar diffusion method with the growth 
inhibition zones expressed in mm. For C. albicans and C. 
krusei nystatin was used as positive control while 




Minimum inhibitory concentrations of the medicinal 
plants 
 
To determine the minimum inhibitory concentration, 
concentrations of the plant extracts varying between 7.5 
and 0.05 mg/ml were tested. Table 4 shows the different 
MICs of the extracts against the three fungal organisms. 
The lowest MICs were obtained with W. salutaris  hexane  
 




Table 1. Ethnobotanical information on the plants used. 
 
Scientific name (Family) Common name (Venda/English) Voucher No 
Plant part 
used Traditional use 










SA08 Bark and Leaves 
Bark for aphrodisiac, venereal diseases, colds, 



















Piles, venereal diseases, anthhelmintic, laxative, 







AS15 Root and Leaves 
Blood in feces, menorrhage, cough, infertility, 






AS18 Root and Tubes 










Broom cluster fig 

















ST07 Bark and Root 
Infected wounds, menorrhage, to dress on magical 
wounds (Mabogo, 1990). 
Rhus rogersii 



















Tennis Ball Bush 




Pride of De Kaap 




coast gold leaf 
BP03 Bark 
Burns, infected wounds, tooth ache, eye pains, 





Fever tea/ Lemon 
Bush 
AS19 Leaves 
Fever, malaria, influenza, measles, lung infections, 
asthma, chronic coughs and pleurisy, 
skin disorders stings and bites (Van Wyk et al., 
1997) . 
 














Velvet sweet berry 






SA12 Bark and Leaves 
Bark, leaves and roots helps stop bleeding, 
heal wounds and treat ring worm, dysentery 
and fever, remedy for leprosy, fruit treat fungal 




















Weeping boer bean 




Buffalo/ Cape thorn 
SA15 Bark 
Boils, skin infections, tubercular gland 










Table 2. Reports from the literature showing similar ethnomedical claims and proven laboratory results showing antifungal activity 
for some of the plants reported by Venda traditional healers. 
 
Plant name Literature reports of related ethnomedical uses and proven antifungal activity 
Berchemia discolor Water extracts were found active against C. albicans (Gundidza and Sibanda, 1991). 
Bridelia micrantha Water extract of the bark showed activity against one of the five clinical strains of C. albicans tested (Steenkamp et al., 2007). 
Cassine transvaalensis Methanol extract of the bark showed activity against the ATCC C. albicans strain but not the clinical strains (Steenkamp et al., 2007).  
Ficus sycomorus Water extracts of the leaves had an MIC of 3.72mg/ml against C. albicans clinical strains (Steenkamp et al., 2007). 
Peltophorum africanum 
The water extract of the root was found active against all the four clinical Candida 
strains while the methanol extract was active against the standard ATCC strain and 
one clinical strain (Steenkamp et al., 2007). 
Piper capense Both the methanol and water extracts were found active against the entire C. albicans strains used (Steenkamp et al., 2007). 
Rhoicisus tridentata Methanol extract exhibited antifungal activity against C. albicans and Saccharomyces cerevisiae (Lin et al., 1999) and C. krusei (Hamza et al., 2006). 
Sclerocaria birrea Stem bark ethanol extracts exhibited strong activity against C. albicans (Adoum et al., 1997) and C. krusei (Hamza et al., 2006). 
Securidata longipedunculata Root bark extracts exhibited antifungal activity against Saccharomyces cerevisiae (Taniguchi et al., 1978). 




bark extract (0.12 mg/ml against C. krusei) and P. 
capense acetone root extract (0.12 mg/ml against C. 
neoformans). W. salutaris hexane bark extract showed an 
MIC of 0.23 mg/ml against both C. albicans and C. 
neoformans, while P. capense acetone root extract 
showed an MIC of 1.88 mg/ml against both Candida 
species tested in the present study.  The hexane extract 
of P. capense root was not as active as the acetone 
extract against C. neoformans (MIC 7.5mg/ml) but was 
more active against Candida sp. with MIC of  3.75 mg/ml. 
 




Table 3. Antifungal activity of medicinal plants as determined by the agar diffusion method (diameter in mm). These 
were the results obtained following 24 h incubation at 37°C on Sabouraud dextrose agar. The results presented are 
for the active plant extracts. 
 
Plant name Solvent and plant part used 
Zone of inhibition (mm) 
C. albicans C. krusei C. neoformans 
5 l 10 l 5 l 10 l 5 l 10 l 
A. fruticosa Hexane (Root) 0 0 0 0 7 12 
B. discolor Hexane (Bark) 0 0 0 0 7 12 
B. discolor Acetone (Leaves 0 0 0 0 0 7 
B. discolor Hexane (Leaves) 10 12 7 10 7 10 
B. galpinii Acetone (Bark) 0 8 0 0 0 12 
B. micrantha Acetone (Bark) 0 0 0 0 10 12 
B. mollis Hexane (Leaves) 0 0 0 0 7 0 
C. tomentosa Hexane (Root) 0 0 0 0 0 7 
C. transvaalensis Acetone (Bark) 0 0 0 0 0 0 
C. transvaalensis Hexane (Bark) 12 16 8 14 14 16 
D. mespiliformis Hexane (Leaves) 7 7 0 0 0 0 
D. mespiliformis Acetone(Bark) 0 0 0 0 10 12 
E. divinorum Hexane (Leaves) 0 0 0 0 0 8 
G. Villosa Hexane (Root) 0 0 0 0 0 8 
L. Javanica Hexane (Leaves) 0 10 0 7 0 0 
P. africanum Acetone (Bark) 0 0 0 0 14 18 
P. capense Acetone (Root) 22 24 24 22 22 16 
P. capense Hexane (Root) 8 12 7 12 0 8 
P. maprouneifolia Hexane (Leaves) 0 10 0 7 0 7 
P. mixtra Acetone (Leaves) 0 0 0 0 18 14 
R. rogersii Acetone (Bark) 0 0 0 0 10 11 
R. tridentata Acetone (Root) 0 0 0 0 8 8 
R. tridentata Acetone (Tubes) 0 0 0 0 8 10 
S. birrea Acetone (Bark) 0 0 0 0 12 14 
S. birrea Hexane (Bark) 0 0 0 0 0 7 
S. brachypetala Acetone (Bark) 0 0 0 0 14 7 
S. brachypetala Hexane (Bark) 0 0 0 0 0 7 
S. decussata Hexane (Bark) 0 0 0 0 0 12 
T. sericea Hexane (Root) 0 0 0 0 0 8 
W. salutaris Acetone (Bark) 7 22 12 10 8 12 
W. salutaris Hexane (Bark) 16 10 14 12 22 22 
W. salutaris Acetone (Leaves) 15 15 10 14 10 12 
W. salutaris Hexane (Leaves) 16 22 12 17 0 7 
X. caffra Acetone (Root) 0 8 0 0 0 0 
X. caffra Hexane (Root) 0 0 0 0 0 8 
X. caffra Hexane (Leave) 0 0 0 0 7 12 
Z. mucronata Acetone (Bark) 0 0 0 0 12 0 
Nystatin  - - 22 - 22 - - 




The acetone extract of W. salutaris bark was not as 
active as the hexane extract and had an MIC of 3.75 
against all the 3 fungal organisms tested. The leaves of 
W. salutaris were not as active as the bark and showed 
an MIC of 1.88 mg/ml against C. krusei for the hexane 
extract   and  1.88 mg/ml  against  C. neoformans  for  the 
acetone extract. The hexane extract from the leaves was 
not active against C. neoformans at the concentration 
tested. Securidaca longepedunculata acetone bark 
extract showed an MIC of 0.23 mg/ml against both C. 
albicans and C. krusei while the MIC against C. 
neoformans was 1.88 mg/ml  and  the  hexane  extract  of 
 




Table 4. Minimum inhibitory concentration (mg/ml) of the active plant extracts against the thee fungal organisms.  
 
Plant name Solvent and plant part used C. albicans C. krusei C. neoformans 
B. discolor Acetone (Bark) 3.75 3.75 > 7.5 
B. discolor Hexane (Bark) 7.5 3.75 7.5 
B. discolor Acetone (Leaves) 0.23 0.47 7.5 
B. discolor Hexane (Leaves) 3.75 3.75 3.75 
B. galpinii Hexane (Bark) 1.88 1.88 > 7.5 
B. galpinii Acetone (Leaves) 0.23 0.23 1.88 
B. galpinii Hexane (Leaves) 1.88 > 7.5 1.88 
B. micrantha Acetone (Bark) > 7.5 0.94 > 7.5 
B. micrantha Hexane (Bark) 3.75 > 7.5 > 7.5 
B. mollis Acetone (Leaves) 3.75 3.75 3.75 
B. mollis Hexane (Leaves) > 7.5 > 7.5 3.75 
C. petersiana Acetone (Bark) > 7.5 > 7.5 1.88 
C. tomentosa Acetone (Root) 3.75 > 7.5 > 7.5 
C. transvaalensis Hexane (Bark) 0.46 1.88 1.88 
L. javanica Acetone (Leaves) > 7.5 1.88 > 7.5 
L. javanica Hexane (Leaves) 3.75 3.75 > 7.5 
M. edulis Acetone (Root) 1.88 3.75 7.5 
M. edulis Hexane (Root) 3.75 0.94 7.5 
P. capense Acetone (Root) 1.88 1.88 0.12 
P. capense Hexane (Root) 3.75 3.75 7.5 
P. maprouneifolia Acetone (Leaves) 1.88 1.88 7.5 
P. maprouneifolia Hexane (Leaves) > 7.5 3.75 > 7.5 
P. mixtra Acetone (Leaves) > 7.5 > 7.5 > 7.5 
P. mixtra Hexane (Leaves) 3.75 > 7.5 > 7.5 
R. rogersii Acetone(Bark) > 7.5 > 7.5 7.5 
R. tridentata Acetone (Tubes) > 7.5 3.75 > 7.5 
R. tridentata Hexane (Tubes) 3.75 3.75 > 7.5 
S. brakipetala Hexane (Bark) 3.75 > 7.5 > 7.5 
S. decussata Acetone (Bark) 3.75 3.75 > 7.5 
S. decussata Hexane (Bark) 3.75 1.88 > 7.5 
S. didymobotyra Acetone (Root) 7.5 7.5 7.5 
S. didymobotyra Hexane (Root) 7.5 7.5 > 7.5 
S. longepedunculata Acetone (Bark) O.23 0.23 1.88 
S. longepedunculata Acetone (Root) > 7.5 > 7.5 1.88 
T. sericea Acetone (Root) 1.88 0.94 > 7.5 
T. sericea Acetone (Bark) 0.94 3.97 1.88 
W. salutaris Acetone (Bark) 3.75 3.75 3.75 
W. salutaris Hexane (Bark) 0.23 0.12 0.23 
W. salutaris Acetone(Leaves) 7.5 7.5 1.88 
W. salutaris Hexane (Leaves) 7.5 1.88 > 7.5 
X. caffra Acetone(Root) 0.94 0.94 3.75 
X. caffra Hexane (Root) > 7.5 > 7.5 7.5 
Nystatin   0.23 µg/ml 0.23 µg/ml - 




the same bark was not active. The leaves of S. 
longepedunculata (both hexane and acetone extracts) 
were not active against both Candida species however, 
the acetone extracts of bark and root showed activity 
against C. neoformans with an MIC of 1.88 mg/ml. B. 
galpinii was active against all the 3 fungi with highest 
activity for this plant observed against both Candida 
species with MIC of 0.23 mg/ml for the acetone leaf 
extract. The same extract showed an MIC of 1.88 mg/ml 
against C. neoformans. The hexane extract of the  leaves  
 




Table 5. Minimum fungicidal concentration (mg/ml) of the active plants against the thee fungal pathogens 
investigated. 
 
Plant name Solvent and Plant part used C. albicans C. krusei C. neofomans 
B. discolor Hexane (Leaves) 7.5 7.5 7.5 
B. discolor Hexane (Bark) 7.5 - - 
C.transvaalensis Hexane (Bark) 3.75 7.5 1.88 
L. javanica Acetone (Leaves) - 7.5 - 
M. edulis Hexane (Root) - - 7.5 
P. capense Acetone (Root) 3.75 3.75 0.11 
P. capense Hexane (Root) 7.5 7.5 7.5 
P.maprouneifolia Hexane (Leaves) 7.5 7.5 - 
W. salutaris Acetone (Bark) 7.5 7.5 3.75 
W. salutaris Hexane (Bark) 0.93 0.46 0.46 




was not as active as the acetone extracts but showed an 
MIC of 1.88 mg/ml for both C. albicans and C. 
neoformans and was not active against C. krusei at the 
highest concentration tested (MIC > 7.5 mg/ml). The 
hexane extract of the bark was more active with MIC of 
1.88 mg/ml against both C. albicans and C. krusei but 
was not active against C. neoformans. The other most 
active plants included B. discolor that appeared to be 
active against all the 3 fungal organisms with the highest 
activity against C. albicans with MIC of 0.23 mg/ml for the 
acetone extract of the leaves. T. sericea acetone extracts 
of the bark as well as X. caffra acetone extract of the root 
showed good activity with MICs of 0.94 mg/ml against C. 
albicans. M. edulis hexane extract from the root also 




Fungicidal activity of the medicinal plants 
 
The capacity of the plant extracts to kill the fungal 
organisms instead of inhibiting their growth was further 
measured and indicated that 7 of the 30 plants tested had 
such activity at concentrations varying between 0.11 and 
7.7 mg/ml (Table 5). These plants included W. salutaris, 
M. edulis, C. transvaalensis, P. capense, P. 
maprouneifolia, B. discolor and L. javanica.  
 
 
Time - kill experiments 
 
The killing curves were determined for all the plants that 
showed fungicidal activity against C. albicans but 
significant changes appeared only for three extracts 
including C. transvaalensis, M. edulis and W. salutaris at 
the concentration of 0.4 mg/ml. Figures 1, 2 and 3 
represent the killing curves for the three extracts that 
showed significant killing activity on C. albicans at the 
concentrations of 1.88, 3.75 and 0.46 mg/ml respectively. 
W. salutaris was active up to the concentration of 0.2 
mg/ml but it was able to kill all the cells (99.99%) at a 





Over the last two decades, fungal infections with special 
reference to Candida sp. and C. neoformans have 
become important public health concerns (Pfaller and 
Diekema, 2004). In South Africa, these infections are 
among the most common opportunistic infections in the 
immuno-compromised individuals causing oropharyngeal 
candidiasis and cryptococcal meningitis due to Candida 
species and C. neoformans, respectively (McCarthy et 
al., 2006). Although C. albicans is the most common 
cause of candidiasis, other Candida species particularly 
Candida glabrata and C. krusei have emerged as 
important cause of oropharyngeal candidiasis and 
candidemia and C. krusei has been shown to be the most 
resistant to antifungal drugs (Fan et al., 2008; Kliemann 
et al., 2008). The objectives of the present study were to 
identify different plants used by local traditional healers in 
the Venda region for the treatment of fungal related 
ailments and to determine the in vitro activities of these 
plants against three fungal organisms including C. 
albicans, C. krusei and C. neoformans isolated from 
South African AIDS patients. It was observed that of most 
of the plants, at least one extract was active against one 
of the fungal organisms.  
Previous studies on Venda medicinal plants have 
targeted bacterial organisms while very few studies have 
been conducted on parasitic and fungal organisms. For 
example, Obi et al. (2003) indicated that Warburgia 
salutaris and Peltophorum africanum were active against 
most of the bacterial organisms tested. The present study 
is thus one of the few to study the antifungal activity of 
medicinal plants  from  this  region.  Out  of  the  30 plants  
 





































Figure 1. Time to kill curve for C. transvaalensis hexane extract (C. Trans H), C. 
transvaalensis acetone extract (C. Trans A) against C. albicans as compared to that of 
the negative control (DMSO) and the positive control nystatin (NYST). The concentration 
of the extracts used in these experiments was 2XMIC (1.88 mg/ml). Nystatin was used 





































Figure 2. Time to kill curve for M. edulis hexane extract (M. Edu H), M. edulis acetone 
extract (M. Edu A) against C. albicans as compared to that of the negative control 
(DMSO) and the positive control nystatin (NYST). The concentration of the extracts used 
in these experiments was 2XMIC (3.75 mg/ml). Nystatin was used at a concentration of 




identified and tested in the present investigation, 6 plants 
including B. micrantha; C. transvaalensis; Ficus 
sycomorus; P. africanum; P. capense and S. decussata 
were previously tested by Steenkamp et al. (2007) 
against C. albicans. In their study, water and methanol 
extracts were used while in the present study, acetone 
and hexane which are two solvent systems of opposite 
polarity were used. This is  important  in  determining  the 
activity of compounds of different polarities. Furthermore; 
the plants extracts were tested against 3 different fungal 
organisms, identifying plants with activity against C. 
krusei and C. neoformans. This study has further 
confirmed the antifungal activity of P. capense against C. 
albicans and determined its activity against C. krusei  and  
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Figure 3. Time to kill curve for W. salutaris hexane extract (W. sal H), W. salutaris acetone 
extract (W. sal A) against C. albicans as compared to that of the negative control (DMSO) 
and the positive control nystatin (NYST). The concentration of the extracts used in these 
experiments was 2XMIC (0.46 mg/ml). Nystatin was used at a concentration of 0.2 µg/ml 




C. neoformans. In their study, Steenkamp et al. (2007) 
did not find any activity with C. transvaalensis water and 
methanol extracts against the clinical C. albicans. How-
ever it was found that the hexane extracts of this plant 
was very active against all the fungal organisms with 
strongest activity against C. albicans isolate (MIC 0.46 
mg/ml) while acetone extracts did not show any activity 
indicating that the active compounds in this plant should 
be non-polar. Steenkamp et al. (2007) also did not find 
any activity against C. albicans clinical isolates when S. 
decussata was used. In the present study, hexane extract 
of S. decussata was active against both C. albicans and 
C. krusei but not against C. neoformans. Also B. 
micrantha showed strong activity against C. krusei with 
MIC value of 0.94 mg/ml for the acetone extract while the 
hexane extract showed moderate activity against C. 
albicans clinical isolate (MIC 3.75 mg/ml).  
In the present study it was found that 10 out of the 30 
plants tested had MIC less than 1 mg/ml against one or 
more fungal organisms tested (Rios and Recio, 2005). 
Similar study by Steenkamp et al. (2007) found that the 
methanol extracts of Combretum molle (root), P. capense 
(bark), Solanum aculeastrum (fruits), Syzygium cordatum 
(bark) and Zanthoxylum davyi (bark) as well as the 
aqueous bark extract of Afzelia quanzensis and root 
extract of Tabernaemontana elegans inhibited clinical C. 
albicans strains at concentrations less than 1 mg/ml. This 
study thus has investigated new plants that have not 
been tested before against fungal organisms and confirm 
the antifungal activity of some plants such as P. capense  
and W. salutaris previously described.  
In this study, W. salutaris was observed to have potent 
fungicidal activities. In traditional medicine, the bark of W. 
salutaris is used as an expectorant and smoked for 
coughs and colds, including a topical application for sores 
and inflammation (Rabe and van Staden, 2000). The 
leaves and bark of W. salutaris have been described to 
contain numerous drimane sesquiterpenoids, including 
warburganal and polygodial. These compounds might be 
responsible for the antimicrobial activities observed with 
this plant. In a study conducted by Kubo and Taniguchi, 
(1988), polygodial was combined with an antibiotic having 
poor cell membrane permeability (actinomycin D) in an 
effort to increase its antibiotic activity by increasing its 
ability to gain entrance into the cell and a remarkably 
enhanced efficacy was obtained and therefore this led to 
a conclusion that polygodial may be acting as an 
"advance scout," punching holes in the plasma 
membrane and gaining an entrance into the cell for an 
antibiotic previously less effective because of problems 
with cell membrane permeability. 
P. capense has been tested by other authors and found 
to have inhibitory properties against C. albicans 
(Steenkamp et al., 2007). Using different solvent systems 
it was also found that this plant was active against three 
different fungal organisms. Further studies on extracts of 
P. capense roots have resulted in the isolation and 
characterization of the novel sesquiterpene capentin 
(Chen et al., 1992). Three new lignans have been 
isolated from the roots of the African shrub P. capense 
and characterized by means of spectroscopic studies and 






compounds include a new 8.O.3'-neolignan, further 
distinguished by an uncommon 1.3.5-trisubstituted ring 
system and two dihydrobenzofuranoid neolignans (Green 
and Wiemer, 1991) and > 58% of hydrocarbons were 
found in the oil of P. capense (Amvam Zollo et al., 1998). 
Although Steenkamp et al. (2007) did not find any anti-C. 
albicans with B. discolor also used by Venda traditional 
healers for the treatment of fungal related ailments, the 
present study found that this plants showed activity 
against all the three fungal organisms tested (by agar 
diffusion and microdilution). This difference might be due 
to the type of solvent used in the two studies, the location 
where the plant was collected or the methodology used. 
Based on present knowledge, no study had identified the 
compounds responsible for the antifungal activity of this 
plant. However, several flavonoid compounds were 
isolated from this plant in Tanzania by Chin et al. (2006). 
These included five new prenylated flavonoids ((6aS, 
11aS)-2-hydroxyleiocarpin Discoloranone A (3S)-
isodiscoloranone A (3S)-discoloranone B and (3S)-
isodiscoloranone) along with 10 known compounds 
including nitidulin, amorphigenin and dabinol. Although 
not verified for their antifungal activity, these or other 
compounds might be responsible of the observed 
antifungal activity in this plant. 
In this study, the hexane extract of C. transvaalensis 
bark was shown to be active against all the three fungal 
species, C. albicans, C. krusei and C. neoformans with 
the MICs ranging from 0.46 to 1.88 mg/ml and inhibition 
zones from 6 to 14mm. In a study done by Motlhanka et 
al. (2008) the roots of C. transvaalensis exhibited strong 
antioxidant activity and thus supported the ethnomedical 
use of this plant to promote good health but they did not 
test this plant for antifungal activity. The acetone root 
extract of T. sericea inhibited the growth of C. albicans 
and C. krusei but not C. neoformans. Masoko et al. 
(2005) found that T. sericea extracts were also the most 
active amongst the six Termialia species that were 
screened against C. albicans, C. neoformans, Aspergillus 
fumigatus, Microsporum canis and Sporothrix schenkii, 
with MIC values ranging between 0.02 to 0.08 mg/ml. In 
the present study W. salutaris was able to kill all the C. 
albicans cells after 5 h while C. transvaalensis were able 
to kill only 75% of the cells after 10 h. The activity of 
extracts from these plants need to be tested against more 
fungal organisms such as Histoplasma capsulatum which 
is also very common among AIDS patients in order to 
identify further beneficial potentials of these plants.  
The activity of the plants tested in the present study was 
not only inhibitory to the fungal organisms but was also 
fungicidal. Such activities have been previously reported 
for other plants and the extent of the fungicidal activity 
has been evaluated by the time-kill experiments 
(Rukayadi et al., 2006). Studies by Okemo et al. (2001) 
indicated that the crude extracts of the neem plant 
Azadirachta indica killed a whole population of C. 
albicans at a concentration of 8 mg/ml in 24 h while Patel  




and Coogan, (2008) found that Dodonaea viscosa 
extracts killed all the C. albicans strains within 30 s. In the 
present study, W. salutaris was able to completely kill C. 
albicans cell at a concentration of 0.4 mg/ml. This 
indicates the possibility of compounds from this plant to 
kill fungal organisms with special reference to Candida 
sp. at lower concentrations than the crude extract. This 
activity could be due to the compounds such as 
muzigadial and warburganal previously isolated from this 
plant in other studies (Rabe and van Staden, 2000). 
Of all the plants tested in the present study, most plants 
were shown to be active. However; some plants 
commonly used by the traditional healers such as F. 
sycomorus, Z. mucronata and S. birrea were not active. 
Although in previous studies by Steenkamp et al. (2007) 
water extracts from F. sycomorus fruits were active, no 
activity in the extracts of the back at the concentration 
tested was found in the present study. This difference in 
activity could be due to the phytochemical differences 
between the two parts of the plant and probably 
geographical differences. Some of the plant may not 
have any effect on the fungal organisms but may play 
important roles such as: facilitating diffusion of active 
compounds into the blood, stabilizing the body 
temperature, reducing the toxicity and taste improving. 
This might explain why most medicinal plants are given in 
a cocktail by the traditional healers. The use of medicinal 
plants can therefore be highly recommendable for fungal 
infections and any other disease and the plants that were 
active can be of great importance for antifungal drug 
synthesis. Population growth, urbanization and the 
unrestricted collection of medicinal plants from the wild is 
resulting in an over-exploitation of natural resources in 
southern Africa. In southern Africa, the most frequently 
used medicinal plants are slow-growing forest trees, 
bulbous and tuberous plants, with bark and underground 
parts being the parts mainly utilized (Zschocke et al., 
2000) and therefore micropropagation of such plants, 
including the plants that were tested active in this 
research can therefore be a great step towards 
conservation sustainability of the plants for future 
medicinal researches. 
This study has identified new plants with antifungal 
activity that could be used as sources for the isolation of 
active compounds that may serve as lead compounds in 
antifungal drug development. This study further justifies 
the use of these plants by traditional healers in the 
region. Further studies on their cytotoxicity or toxicity will 
be beneficial in providing data on the possible harmful 
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